| Literature DB >> 31284406 |
Youn-Jung Son1, Kyounghoon Lee2, Bo-Hwan Kim3.
Abstract
Atrial fibrillation (AF), common in older adults, increases the risk of heart failure, stroke, and all-cause mortality. Self-care behaviors help avoid adverse events in older patients with AF. However, while frailty and cognitive impairment can contribute to poor self-care behaviors, few studies have explored these relationships in older adults with AF. This cross-sectional study aims to determine associations between frailty, cognitive impairment, and self-care behaviors among older adults with AF by gender. A total of 298 patients with AF aged 60 and over were assessed with a self-reported questionnaire consisting of the Korean version of the FRAIL scale, modified mini-mental state examination, and self-care scale for AF. Prevalence of frailty and prefrailty in men and women was around 11% and 48.4% and 28% and 47.4%, respectively. According to the hierarchical linear regression analysis, in men, prefrailty (β = -2.874, p = 0.013) and frailty (β = -7.698, p < 0.001) were associated with self-care behaviors; in women, frailty (β = -5.476, p = 0.003), and cognitive impairment (β = -3.350, p = 0.044) were associated with self-care behaviors. Developing individualized care plans will require periodic screening of older patients with AF to determine their frailty status and cognitive function.Entities:
Keywords: atrial fibrillation; cognition; frailty; gender; self-care behaviors
Mesh:
Year: 2019 PMID: 31284406 PMCID: PMC6651572 DOI: 10.3390/ijerph16132387
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sociodemographic characteristics by gender and frailty status (n = 298).
| Characteristics | Total | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Robust | Prefrail | Frail |
| Robust | Prefrail | Frail |
| ||
| Age (years) * | 72.11 (7.51) | 69.47 (7.22) | 71.78 (7.33) † | 74.05 (6.57) †‡ | 0.019 | 71.00 (7.56) | 73.65 (6.93) | 76.28 (7.93) † | 0.024 |
| 60–69 | 119 (39.9) | 42 (56.8) | 35 (39.3) | 4 (19.0) | 0.016 | 15 (53.6) | 16 (29.6) | 7 (21.9) | 0.037 |
| 70–79 | 122 (40.9) | 25 (33.8) | 38 (42.5) | 12 (57.1) | 6 (21.4) | 27 (50.0) | 14 (43.8) | ||
| ≥80 | 57 (19.1) | 7 (9.5) | 16 (18.0) | 5 (23.8) | 7 (25.0) | 11 (20.4) | 11 (25.4) | ||
| Educational level | |||||||||
| Below middle school | 169 (56.7) | 30 (40.5) | 35 (39.3) | 15 (71.4) | 0.023 | 19 (67.9) | 43 (79.6) | 27 (84.4) | 0.283 |
| Above high school | 129 (43.3) | 44 (59.5) | 54 (60.7) | 6 (28.6) | 9 (32.1) | 11 (20.4) | 5 (15.6) | ||
| Family type | |||||||||
| Live alone | 57 (19.1) | 6 (8.1) | 12 (13.5) | 5 (23.8) | 0.147 | 5 (17.9) | 14 (25.9) | 15 (46.9) | 0.034 |
| Live with family | 241 (80.9) | 68 (91.9) | 77 (86.5) | 16 (76.2) | 23 (82.1) | 40 (74.1) | 17 (53.1) | ||
| Job (yes) * | 72 (24.2) | 30 (40.5) | 22 (24.7) | 4 (19.0) | 0.047 | 5 (17.9) | 10 (18.5) | 1 (3.1) | 0.086 |
| Monthly income (KRW) | |||||||||
| <1,000,000 | 136 (45.6) | 19 (25.7) | 44 (49.4) | 15 (71.4) | < 0.001 | 7 (25.0) | 27 (50.0) | 24 (75.0) | 0.001 |
| ≥1,000,000 | 162 (54.4) | 55 (74.3) | 45 (50.6) | 6 (28.6) | 21 (75.0) | 27 (50.0) | 8 (25.0) | ||
| BMI (kg/m2) ** | 24.38 (2.94) | 24.37 (2.31) | 24.53 (2.79) | 23.37 (4.08) | 0.232 | 24.14 (3.38) | 24.62 (3.17) | 24.47 (3.03) | 0.811 |
| Underweight (< 20) | 18 (6.0) | 3 (4.1) | 3 (3.5) | 3 (15.8) | 0.132 | 2 (7.7) | 4 (7.8) | 3 (9.7) | 0.990 |
| Normal (20–25) | 166 (55.7) | 45 (60.8) | 50 (58.1) | 13 (68.4) | 15 (57.7) | 27 (52.9) | 16 (51.6) | ||
| Overweight (> 25) | 103 (34.6) | 26 (35.1) | 33 (38.4) | 3 (15.8) | 9 (34.6) | 20 (39.2) | 12 (38.7) | ||
All the data were included in Table 1; * Fisher’s exact test, ** summation of percentage is not equal to 100% because of missing data, † significance compared to robust, ‡ significance compared to prefrail; p < 0.05; BMI, body mass index.
Clinical characteristics by gender and frailty status (n = 298).
| Characteristics | Total | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Robust | Prefrail | Frail |
| Robust | Prefrail | Frail |
| ||
| Year after diagnosis of atrial fibrillation (AF) | 7.96 (6.22) | 9.29 (7.82) | 7.63 (5.60) | 7.02 (5.15) | 0.184 | 7.36 (4.72) | 8.13 (6.21) | 6.70 (5.29) | 0.513 |
| Type of AF* | |||||||||
| Paroxysmal | 184 (61.7) | 43 (58.1) | 49 (55.1) | 12 (56.5) | 0.980 | 19 (67.9) | 41 (75.9) | 20 (62.5) | 0.412 |
| Persistent | 105 (35.2) | 28 (37.8) | 36 (40.4) | 9 (42.9) | 8 (28.6) | 13 (24.1) | 11 (34.4) | ||
| Permanent | 9 (3.0) | 3 (4.1) | 4 (4.5) | 0 (0.0) | 1 (3.6) | 0 (0.0) | 1 (3.1) | ||
| CHA2DS2-VASc * | |||||||||
| Low and intermediate risk (0–1) | 36 (12.1) | 20 (27.0) | 10 (11.2) | 2 (9.5) | 0.021 | 2 (7.1) | 2 (3.7) | 0 (0.0) | 0.268 |
| High stroke risk (≥ 2) | 262 (87.9) | 54 (73.0) | 79 (88.8) | 19 (90.5) | 26 (92.9) | 52 (96.3) | 32 (100.0) | ||
| HAS-BLED score * | |||||||||
| Low and intermediate risk (0–2) | 71 (23.8) | 28 (37.8) | 18 (20.2) | 3 (14.3) | 0.017 | 10 (35.7) | 7 (13.0) | 5 (15.6) | 0.039 |
| High bleeding risk (≥ 3) | 227 (76.2) | 46 (62.2) | 71 (79.8) | 18 (85.7) | 18 (64.3) | 47 (87.0) | 27 (84.4) | ||
| Comorbidities | |||||||||
| Hypertension (yes) * | 229 (76.8) | 45 (60.8) | 72 (80.9) | 19 (90.5) | 0.003 | 23 (82.1) | 45 (83.3) | 25 (78.1) | 0.831 |
| Diabetes mellitus (yes) | 81 (27.2) | 14 (18.9) | 23 (25.8) | 7 (33.3) | 0.329 | 7 (25.0) | 17 (31.5) | 13 (40.6) | 0.426 |
| Coronary artery disease (yes) | 92 (30.9) | 23 (31.1) | 24 (27.0) | 9 (42.9) | 0.359 | 8 (28.6) | 16 (29.6) | 12 (37.5) | 0.694 |
| Heart failure (yes) | 115 (38.6) | 19 (25.7) | 35 (39.3) | 14 (66.7) | 0.002 | 9 (32.1) | 20 (37.0) | 18 (56.3) | 0.115 |
| Stroke (yes) * | 62 (20.8) | 12 (16.2) | 21 (23.6) | 7 (33.3) | 0.205 | 5 (17.9) | 14 (25.9) | 3 (9.4) | 0.187 |
| Renal failure (yes) * | 9 (3.0) | 0 (0.0) | 5 (5.6) | 3 (14.3) | 0.010 | 0 (0.0) | 0 (0.0) | 1 (3.1) | 0.526 |
| Medications | |||||||||
| Aspirin (yes) | 131 (44.0) | 44 (59.5) | 37 (41.6) | 9 (42.9) | 0.063 | 12 (42.9) | 16 (29.6) | 13 (40.6) | 0.402 |
| Warfarin (yes) | 104 (34.9) | 23 (31.1) | 34 (38.2) | 6 (28.6) | 0.536 | 14 (50.0) | 20 (37.0) | 7 (21.9) | 0.075 |
| NOAC (yes) | 86 (28.9) | 22 (29.7) | 23 (25.8) | 6 (28.6) | 0.855 | 6 (21.4) | 17 (31.5) | 12 (37.5) | 0.398 |
| Lab data ** | |||||||||
| Hb (mg/dL) | 13.53 ± 1.83 | 14.47 ± 1.29 | 13.86 ± 1.86 † | 12.93 ± 2.48 †‡ | 0.002 | 13.01 ± 1.44 | 12.65 ± 1.46 | 12.75 ± 2.00 | 0.651 |
| Hct (%) | 40.05 ± 5.26 | 42.14 ± 4.87 | 40.95 ± 5.20 | 38.64 ± 6.46 † | 0.026 | 38.80 ± 4.27 | 37.93 ± 4.28 | 38.31 ± 5.58 | 0.732 |
| PT (sec) | 18.44 ± 9.18 | 17.16 ± 7.45 | 19.82 ± 11.43 | 17.92 ± 9.18 | 0.233 | 19.41 ± 8.90 | 19.25 ± 8.34 | 15.63 ± 6.59 | 0.102 |
| PTT (sec) | 35.10 ± 10.55 | 34.88 ± 9.74 | 35.37 ± 9.26 | 33.91 ± 7.36 | 0.818 | 36.76 ± 15.40 | 35.22 ± 13.17 | 34.16 ± 8.52 | 0.765 |
| INR | 1.67 ± 0.85 | 1.54 ± 0.66 | 1.76 ± 1.01 | 1.79 ± 1.17 | 0.271 | 1.79 ± 0.78 | 1.70 ± 0.74 | 1.43 ± 0.63 | 0.134 |
All the data were included in Table 2; * Fisher’s exact test; ** summation of percentage is not equal to 100% due to missing data, † significance compared to robust, ‡ significance compared to prefrail; p < 0.05; NOAC, new oral anticoagulants; Hb, hemoglobin; Hct, hematocrit; PT, prothrombin time; PTT, partial thromboplastin time; INR, international normalized ratio.
Differences in cognitive function and self-care behaviors by gender and frailty (N = 298).
| Variables | Total | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Robust | Prefrail | Frail |
| Robust | Prefrail | Frail |
| ||
| Cognitive function * | |||||||||
| Impairment (≤ 72) | 45 (15.1) | 4 (5.4) | 8 (9.0) | 4 (19.0) | 0.143 | 3 (10.7) | 10 (18.5) | 16 (50.0) | 0.001 |
| Normal (> 73) | 253 (84.9) | 70 (94.6) | 81 (91.0) | 17 (81.0) | 25 (89.3) | 44 (81.5) | 16 (50.0) | ||
| Self-care behaviors | 31.71 (7.06) | 34.92 (6.29) | 32.00 (6.86) † | 26.29 (5.69) †‡ | < 0.001 | 34.54 (6.57) | 30.72 (6.84) † | 26.22 (5.22) †‡ | <0.001 |
* Fisher’s exact test, † significance compared to robust, and ‡ significance compared to prefrail; p < 0.05.
Hierarchical linear regression analysis of self-care behaviors in male patients with AF (n = 184).
| Predictors | Step 1 | Step 2 | ||||
|---|---|---|---|---|---|---|
|
| 95% CI |
| 95% CI | |||
| Age (years) | −0.104 | −1.121 (0.264) | −0.287 to 0.079 | −0.059 | −0.641 (0.523) | −0.240 to 0.122 |
| Educational level | −1.680 | −1.536 (0.126) | −3.838 to 0.479 | −1.132 | −1.057 (0.292) | −3.246 to 0.983 |
| Job (no) | 2.692 | 1.950 (0.053) | −0.035 to 5.419 | 2.274 | 1.720 (0.087) | −0.338 to 4.885 |
| Monthly income (< 1,000,000 KRW) | −2.575 | −2.089 (0.038) | −5.010 to −0.141 | −1.336 | −1.098 (0.274) | −3.740 to 1.068 |
| CHA2Ds2-VASc (high stroke risk) | −0.243 | −0.134 (0.893) | −3.827 to 3.340 | −0.354 | −0.203 (0.839) | −3.801 to 3.092 |
| HAS-BLED (high bleeding risk) | 0.136 | 0.078 (0.938) | −3.302 to 3.575 | −0.268 | −0.161 (0.872) | −3.556 to 3.020 |
| Hypertension | −0.905 | −0.595 (0.553) | −3.911 to 2.101 | 0.294 | 0.198 (0.843) | −2.634 to 3.221 |
| Heart failure | −0.636 | −0.567 (0.572) | −2.854 to 1.581 | 0.445 | 0.402 (0.688) | −1.744 to 2.634 |
| Renal failure | −0.299 | −0.092 (0.927) | −6.699 to 6.102 | 0.469 | 0.151 (0.880) | −5.677 to 6.616 |
| Hb (g/dL) | 0.729 | 1.210 (0.228) | −0.461 to 1.919 | 0.475 | 0.821 (0.413) | −.668 to 1.618 |
| Hct (%) | −0.079 | −0.407 (0.685) | −0.463 to 0.305 | −0.089 | −0.480 (0.632) | −0.457 to 0.278 |
| Prefrail | −2.874 | −2.523 (0.013) | −5.123 to −0.624 | |||
| Frail | −7.698 | −4.044 (< 0.001) | −11.458 to −3.939 | |||
| Cognitive impairment | −2.528 | −1.310 (0.192) | −6.341 to 1.285 | |||
| Adjusted R2 = 0.053, F ( | Adjusted R2 = 0.139, F ( | |||||
CI, confidence interval; Hb, hemoglobin; Hct, hematocrit; dummy variables: educational level (reference = over high school), job (reference = yes), CHA2Ds2-VASC (reference = low and intermediate risk), HAS-BLED (reference = low and intermediate risk), and prefrail and frail (reference = robust).
Hierarchical linear regression analysis of self-care behaviors in female patients with AF (n = 114).
| Predictors | Step 1 | Step 2 | ||||
|---|---|---|---|---|---|---|
|
| 95% CI |
| 95% CI | |||
| Age (years) | −0.194 | −2.122 (0.036) | −0.375 to −0.013 | −0.054 | −0.553 (0.581) | −0.248 to 0.140 |
| Family type (live alone) | 0.082 | 0.055 (0.956) | −2.868 to 3.031 | 0.757 | 0.533 (0.595) | −2.059 to 3.573 |
| Monthly income (<1,000,000 KRW) | −3.513 | −2.525 (0.013) | −6.272 to −0.754 | −2.045 | −1.494 (0.138) | −4.760 to 0.670 |
| HAS-BLED (high bleeding risk) | 1.010 | 0.588 (0.558) | −2.396 to 4.415 | 1.088 | 0.658 (0.512) | −2.191 to 4.368 |
| Prefrail | −2.482 | −1.605 (0.112) | −5.550 to 0.586 | |||
| Frail | −5.476 | −3.005 (0.003) | −9.090 to −1.862 | |||
| Cognitive impairment | −3.350 | −2.040 (0.044) | −6.608 to −0.093 | |||
| Adjusted R2 = 0.150, F ( | Adjusted R2 = 0.244, F ( | |||||
CI, confidence interval; dummy variables: family type (reference = live together), monthly income (reference = ≥ 1,000,000 KRW), HAS-BLED (reference = low and intermediate risk), and prefrail and frail (reference = robust).